Updates in the Treatment of HR+ Breast Cancer : Episode 1
Opinion
Video
Expert Insights on Biomarker Testing in Early-Stage Breast Cancer
Author(s):
Leading oncologists explore optimal biomarker testing strategies for early-stage breast cancer, examining the comparative advantages of tissue and liquid biopsies to guide personalized treatment decisions.
- Best practices for biomarker testing in early-stage breast cancer
- Dr. McCann to ask Dr Hurvitz:What are you typically testing for in early-stage breast cancer? (HR, PR, HER2, others?)
- Dr McCann to ask Dr Kaklamani:What testing methodologies are most typically used? How do they differ and what can you learn from each? (NGS, FISH, IHC, panels, etc.)What sample types are best? (tissue vs. liquid)
- Dr McCann to ask Dr Pegram:How do results guide treatment?
Related Videos
Related Content
